RxDoctor Payments Data

Rickman Powers

Psychiatric/Mental Health · Cookeville, TNNPI 1770985855

Payments from drug & device makers

$346in general payments, 2019–2025

Across 20 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$128
  • Vanda Pharmaceuticals Inc.$63
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$40
  • Teva Pharmaceuticals USA, Inc.$38
  • Alkermes, Inc.$36
  • Otsuka America Pharmaceutical, Inc.$27
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$346 in reported general payments places this provider in the 35th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$31,257
Medicare patients
99
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine40$331,158
IngrezzaValbenazine Tosylate18$142,647
Invega SustennaPaliperidone Palmitate26$89,551
VraylarCariprazine Hcl43$66,773
Abilify MaintenaAripiprazole20$59,642
Lurasidone Hcl44$27,945
TrintellixVortioxetine Hydrobromide29$16,756
Fluphenazine Hcl86$11,807
Clozapine55$8,768
Ziprasidone Hcl88$8,185
Haloperidol193$6,200
Aripiprazole121$4,589
Quetiapine Fumarate217$4,432
Benztropine Mesylate289$4,088
Paliperidone ErPaliperidone31$4,049

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$38$331,15840 claims
Johnson & JohnsonInvega Sustenna$14$89,55126 claims
AbbVieVraylar$128$66,77343 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$27$59,64220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Cookeville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →